drugset / Trial / NCT04056611
Effects of JNJ-53718678 in Adult and Adolescent Participants Who Had a Hematopoietic Stem Cell Transplantation and Who Are Infected With Respiratory Syncytial Virus (RSV)
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the effect of JNJ-53718678 on the development of respiratory syncytial virus (RSV) lower respiratory tract infection (LRTIs) in adult hematopoietic stem cell transplant (HSCT) recipients with RSV upper RTI.
Timeline
- Start
- 2019-12-26
- Primary completion
- 2022-02-04
- Completion
- 2022-02-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rilematovir | Other / unclassified | 125 mg | Oral |
| Subject | Rilematovir | Other / unclassified | 250 mg | Oral |